VIVEbiotech is a company fully specialized in lentiviral vectors.
As a GMP Contract Development and Manufacturing Organization (CDMO), we are specialized in lentiviral vector bioprocess development (from very early stages) and GMP manufacturing. VIVEbiotech has experience in manufacturing lentiviral vectors for different applications such as cancer immune-cell therapy projects (CAR-Ts/TCRs…) and rare diseases, among others.
Currently, we are working with companies based in Europe, US and Australia being highly flexible in terms of technical adaptation.
Additionally, VIVEbiotech is continuously working on the enhancement of lentiviral vector properties focusing on the development of cost-effective processes and safer lentiviral vectors (world-wide patented technology).